Biblio Discovery — Demo Discovery Service

3 hasil untuk "Shaji Kumar"

Menampilkan 1–3 · 1,30 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Anti-Myeloma Activity of Akt Inhibition Is Linked to the Activation Status of PI3K/Akt and MEK/ERK Pathway

    Vijay Ramakrishnan; Teresa Kimlinger; Jessica Haug dkk.

    PLoS ONE, Vol. 7 No. 11 · 2012 · Inggris · PLOS Scopus

    The PI3K/Akt/mTOR signal transduction pathway plays a central role in multiple myeloma (MM) disease progression and development of therapeutic resistance. mTORC1 inhibitors have shown limited efficacy in the clinic, largely attributed to the reactivation of Akt due to rapamycin induced mTORC2…

  2. Artikel Jurnal Teks lengkap

    RWD-derived response in multiple myeloma

    Tao Xu; James Roose; Mellissa Williamson dkk.

    PLOS ONE, Vol. 18 No. 5 · 2023 · Inggris · PLOS Scopus

    Real-world data (RWD) are important for understanding the treatment course and response patterns of patients with multiple myeloma. This exploratory pilot study establishes a way to reliably assess response from incomplete laboratory measurements captured in RWD. A rule-based algorithm, adapted…

  3. Artikel Jurnal Teks lengkap

    Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk

    Rosalie G. Waller; Todd M. Darlington; Xiaomu Wei dkk.

    PLOS Genetics, Vol. 14 No. 2 · 2018 · Inggris · PLOS Scopus

    The high-risk pedigree (HRP) design is an established strategy to discover rare, highly-penetrant, Mendelian-like causal variants. Its success, however, in complex traits has been modest, largely due to challenges of genetic heterogeneity and complex inheritance models. We describe a HRP strategy…